Teva files opposition against Benedyka trademark
Summary
Teva Pharmaceuticals International GmbH filed a Notice of Default against Benedyka Nutrition Health Inc. at the USPTO Trademark Trial and Appeal Board. The opposition (No. 91304677) concerns the BENEDYKA trademark. The filing date of the opposition was January 21, 2026.
What changed
Teva Pharmaceuticals filed a trademark opposition against Benedyka Nutrition Health Inc. regarding the BENEDYKA mark (Opposition No. 91304677). A Notice of Default was issued, indicating Benedyka failed to timely respond or appear in the proceeding. The opposition was filed January 21, 2026, with the Notice dated April 3, 2026.
Benedyka Nutrition Health Inc. must monitor this proceeding and consider responding to the Notice of Default to avoid having its trademark application abandoned. Legal counsel should advise on appropriate responsive actions within TTAB deadlines. Trademark applicants facing opposition proceedings should ensure timely participation to preserve their registration rights.
What to do next
- Monitor TTAB proceedings for response deadlines if representing Benedyka
- Consult trademark counsel if a similar mark is involved
- Review internal trademark portfolios for potential conflicts
Source document (simplified)
Opposition: BENEDYKA
Opposition TTAB91304677-20260403 Kind: OPP Apr 03, 2026
Abstract
NOTICE OF DEFAULT
Plaintiff: Teva Pharmaceuticals International GmbH
Defendant: Benedyka Nutrition Health Inc.
Mark at issue: BENEDYKA
Filing Date
2026-01-21
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Courts & Legal alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: TTAB Proceedings publishes new changes.